| # | Drug | Count |
|---|---|---|
| 0 | WARFARIN | 63 |
| 1 | WARFARIN SODIUM | 57 |
| 2 | CYTARABINE | 38 |
| 3 | RIVAROXABAN | 33 |
| 4 | BEVACIZUMAB | 31 |
| 5 | IBRUTINIB | 28 |
| 6 | DEXAMETHASONE | 26 |
| 7 | DEXAMETHASONE 1.5 MG | 26 |
| 8 | CYCLOPHOSPHAMIDE | 25 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROPAFENONE | 9 | 0.0021 |
| 1 | ARSENIC TRIOXIDE | 4 | 0.0017 |
| 2 | THIOGUANINE | 3 | 0.0014 |
| 3 | FENOFIBRIC ACID | 1 | 0.0013 |
| 4 | TENECTEPLASE | 2 | 0.0013 |
| 5 | IPTACOPAN | 1 | 0.0013 |
| 6 | BELZUTIFAN | 2 | 0.0011 |
| 7 | GEMTUZUMAB OZOGAMICIN | 4 | 0.0011 |
| 8 | IMIPENEM AND CILASTATIN SODIUM | 2 | 0.0009 |
| 9 | ANAGRELIDE HYDROCHLORIDE | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 59 |
| 1 | Kinase Inhibitor [EPC] | 48 |
| 2 | Corticosteroid [EPC] | 44 |
| 3 | Factor Xa Inhibitor [EPC] | 41 |
| 4 | Alkylating Drug [EPC] | 39 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 33 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 24 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 8 | Topoisomerase Inhibitor [EPC] | 19 |
| 9 | Platinum-based Drug [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 1 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 2 | Surfactant [EPC] | 1 | 0.0009 |
| 3 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 4 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 5 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 7 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 8 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 9 | Topoisomerase Inhibitor [EPC] | 19 | 0.0002 |